AIDS 2018: Programme online and late-breaker highlights announced three weeks before the conference

Simon Collins, HIV i-Base

Three weeks ahead of the upcoming International AIDS Conference (AIDS 2018) the meeting organisers have posted the schedule and programme online.

The pre-conference publicity has also announced their pick of late-breaker highlights.

PARTNER2: as follow-up to the landmark PARTNER study, additional evidence will be presented from the extension study that continued to enroll and follow gay couples.
GEMINI studies: Results from two large phase 3 studies randomising treatment-naive participants to either dolutegravir plus lamivudine dual therapy or triple therapy.
Dolutegravir and pregnancy: late breaking findings, interpretations and implications.
ANRS PREVENIR study: using daily and “on demand” PrEP in men who have sex with men.
PrEP and hormone therapy: new studies in transgender women.
UK RIVER study: results from the first randomised controlled trial of a “kick and kill” approach to HIV reservoirs.
Prevention and treatment studies in key countries, including results from the Namibia Population-Based HIV Impact Assessment (PHIA).
SEARCH study: on HIV “test-and-treat” using a multi-disease approach and streamlined care in Kenya and Uganda.
Cost-effective strategies that could halve HIV infections and deaths in Ukraine.

These highlights show that IAS 2018 will be a focus for important research with implications for current treatment and prevention strategies.

This is the first time that so much material has been released this far ahead of the actual meeting, either for press or for open-access.

It is essential to wait for the presentations, even when the title of the presentations are less than neutral for the results.

Reference

IAS press release. AIDS 2018 programme online. (29 June 2018).
http://programme.aids2018.org

Links to other websites are current at date of posting but not maintained.